AIM IMMUNOTECH INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31)
AIM IMMUNOTECH INC. (AIM) reported Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) of $160.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses · last filed 2015-03-19
- AIM IMMUNOTECH INC. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $34.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $103.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for the quarter ending 2014-06-30 was -$70.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $93.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for fiscal 2014 was $160.00K, a 30.13% decline from fiscal 2013.
- AIM IMMUNOTECH INC. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for fiscal 2013 was $229.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $137.00K derived: sum of 2 quarters · filed 2015-03-19 | $67.00K derived: sum of 3 quarters · filed 2015-03-19 | $160.00K 10-K · filed 2015-03-19 |
| 2014-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $33.00K derived: sum of 2 quarters · filed 2014-11-07 | $126.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $23.00K 10-Q · filed 2014-08-08 | ||
| 2014-03-31 | $93.00K 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | $229.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |